Fmoc-D-Leucine

Fmoc-D-Leucine is a D-configured leucine amino acid derivative bearing an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) protecting group on the amino functionality and a free carboxylic acid suitable for peptide coupling chemistry. The side chain isopropyl group of leucine provides a hydrophobic, stereochemically defined chiral center that influences conformational preferences in peptide backbones and peptidomimetics. The Fmoc carbamate is stable under many base-tolerant conditions used in solid-phase synthesis, while the carboxylic acid participates in amide bond formation after activation. The overall structure functions as a chiral, protected amino acid building block with predictable reactivity for generating D-amino acid-containing peptides and downstream synthetic intermediates.

1. Peptide Synthesis

Fmoc-D-Leucine is used in peptide building block preparation for both solution-phase and solid-phase peptide synthesis where D-amino acid incorporation is required. The Fmoc-protected amine supports controlled deprotection and subsequent coupling, while the free carboxyl group enables formation of amide linkages to neighboring residues under standard peptide coupling activation. The D-stereochemistry at the alpha carbon allows access to stereochemically defined peptide sequences that can modulate backbone orientation and protease resistance profiles in peptidic constructs. The resulting D-Leu-containing peptides serve as research reagents for peptide library generation, scaffold diversification, and structure-activity relationship studies in medicinal chemistry.

2. Peptidomimetics And SAR

Fmoc-D-Leucine is applied in peptidomimetic construction and SAR studies where hydrophobic leucine side-chain geometry and D-configuration contribute to binding-site complementarity. The isopropyl side chain can be retained as a key steric and hydrophobic element while the protected amino acid format supports iterative assembly of analogs with consistent stereochemical control. Fmoc-D-Leucine can be incorporated into peptide-like scaffolds that are subsequently diversified at termini or side chains through orthogonal functional group transformations. Downstream derivatives generated from this building block are suitable for fragment-based molecular design workflows and comparative SAR campaigns requiring defined stereochemical composition.

3. Protein Engineering

Fmoc-D-Leucine is relevant to protein engineering workflows that require chemically synthesized segments containing D-amino acids, such as engineered peptide domains, stapled motifs, or protease-resistant linkers. The protected amino acid backbone enables stepwise assembly of D-residue-containing oligopeptides that can be used as ligation partners or as defined substrates in biochemical assays. The Fmoc group strategy supports compatibility with automated peptide synthesis platforms, while the leucine hydrophobic side chain can be used to tune local folding propensity in synthetic constructs. The ability to generate stereochemically defined D-amino acid segments supports downstream formation of functional biomolecular tools for studying sequence-dependent behavior.

4. Chemical Biology Labeling

Fmoc-D-Leucine is used in chemical biology research for constructing labeled peptide probes where D-amino acid stability and hydrophobic residue placement improve probe integrity during handling and analytical workflows. The Fmoc-protected amine and carboxylic acid allow the building block to be incorporated into peptide sequences that later undergo terminal modification or conjugation to tags such as fluorophores, affinity handles, or mass spectrometry reporters. The D-configuration can reduce enzymatic cleavage by proteases, which may help maintain probe composition during incubation-based assays and sample processing. The resulting derivatized peptides function as analytical and mechanistic reagents for mapping molecular interactions and monitoring biochemical processes.

5. Pharmaceutical Intermediate Preparation

Fmoc-D-Leucine serves as a chiral amino acid intermediate for fine chemical synthesis routes that require D-leucine incorporation into drug-like scaffolds or peptide-based candidates. The Fmoc carbamate protection provides a robust handle for controlled coupling chemistry, enabling synthesis of D-amino acid-containing intermediates that can be further transformed after peptide assembly or selective deprotection strategies. The leucine side chain and stereocenter support downstream derivatization into amide-linked fragments, constrained peptidomimetics, or termini-modified building blocks used in medicinal chemistry programs. Process-oriented manufacturing of such intermediates benefits from the predictable protection/deprotection behavior and the stereochemical integrity maintained from the protected amino acid stage.

6. Analytical Standards for D-Peptides

Fmoc-D-Leucine is suitable for developing analytical standards and reference materials involving D-amino acid-containing peptides used in method development and stereochemical verification. The protected amino acid format allows preparation of defined D-leucine-containing peptide sequences that can be used to calibrate chromatographic separation, confirm identity by mass spectrometry, or support method qualification for chiral analysis. The Fmoc group enables reproducible synthesis of reference peptides with controlled sequence composition, while the leucine hydrophobicity helps generate analytes with distinct retention behavior. D-peptide standards prepared from this building block can support routine analytical research and quality-focused characterization of amino acid derivative products.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

3. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

4. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

5. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide